Mirikizumab (Omvoh) is available on the NHS as a possible treatment for moderately to severely active Crohn's disease in adults when: a previous biological treatment has not worked well enough, has ...

Fatigue and exhaustion are hallmarks of Crohn's disease. Try these tips for more energy and better health overall.

Background The development of IBD is known to involve early immunological alterations, but our understanding of the changes in antibody epitope repertoires moving from the prediagnostic phase towards ...

Cartabuke: The biggest challenges in the treatment of Crohn’s disease include managing refractory disease, preventing and treating complications, and addressing the high cost of biologic therapies.

Bhat: I am an embedded clinical pharmacist and a part of the IBD medical home at Cleveland Clinic. In caring for patients with Crohn’s disease, I meet with patients independently 1:1 to ...

Physicians treating patients with Crohn's disease face a plethora of drug choices. Yet, overall rates of clinical response seem stable over time,1 suggesting the existence of a therapeutic ceiling ...

Our findings provide evidence for the potential use of DNA methylation as a modality for personalised medicine for Crohn's disease by predicting response to vedolizumab and ustekinumab. The models ...